Associated Papers
Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers.
Buzkova J et al.
Embo Molecular Medicine, 2018
30373890 (PubMed )
Supplement: EMMM-10-e9091-s004.xlsx › patients
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
Suomalainen A et al.
The Lancet. Neurology, 2011
Select a paper to view details